These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15213859)

  • 21. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
    Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
    Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
    J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Nov; 102(5):945-50. PubMed ID: 19888533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordinated release of tissue factor and tissue factor pathway inhibitor in VLBW infants.
    Palojärvi A; Andersson S; Långström S; Petäjä J
    Acta Paediatr; 2013 Jun; 102(6):584-9. PubMed ID: 23458419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty.
    Marcucci R; Prisco D; Brunelli T; Pepe G; Gori AM; Fedi S; Capanni M; Simonetti I; Federici G; Pastore A; Abbate R; Gensini GF
    Thromb Haemost; 2000 Jun; 83(6):826-32. PubMed ID: 10896233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
    Lekhal S; Børvik T; Nordøy A; Hansen JB
    Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):700-6. PubMed ID: 18194851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
    Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
    J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration.
    Cardigan RA; McGloin H; Mackie IJ; Machin SJ; Singer M
    Kidney Int; 1999 Apr; 55(4):1568-74. PubMed ID: 10201024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
    Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
    Hedner U; Erhardtsen E
    Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct inhibition of factor VIIa by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2013 Apr; 11(4):704-14. PubMed ID: 23347185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
    El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.
    Jesty J; Lorenz A; Rodriguez J; Wun TC
    Blood; 1996 Mar; 87(6):2301-7. PubMed ID: 8630391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
    Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
    Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction?
    Bennermo M; Held C; Ericsson CG; Silveira A; Hamsten A; Tornvall P
    Thromb Haemost; 2005 Aug; 94(2):427-31. PubMed ID: 16113835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.